510(k) Report

510(k) · Cleared

Cleared

Health Line International Corporations,S IV Administrative Sets

K060352510(k) TraditionalCleared May 31, 2006107-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Health Line International Corporation · FPA Set, Administration, Intravascular

Cleared on May 31, 2006 after a 107-day review. The summary cites 2 numbers, none of which could be confirmed as its predicate (see the table below). 2 of the 14 devices in its family, counting itself, have a Class I recall. 13 later devices descend from it.

Decided
May 31, 2006
Review
107 days
Class
Class II
Product code
FPA
Recalls
None
Predicates
2

13 later devices descend from it, 1 citing it directly. 2 of the 14 devices in this family, counting this one, have a Class I recall.

Descendants, by year cleared 2012: 1 descendant cleared2024: 2 descendants cleared2016: 1 descendant cleared, 1 with a Class I recall12015: 1 descendant cleared2014: 2 descendants cleared, 1 with a Class I recall12026: 1 descendant cleared2020: 1 descendant cleared2023: 1 descendant cleared2018: 1 descendant cleared2022: 1 descendant cleared2025: 1 descendant cleared20052010201520202025
  1. This deviceK060352 Health Line International Corporations,S IV Administrative SetsHealth Line International Corporation · 2006
  2. Descendant · cites it directly · 12 of its ownK120685 Zyno Medical Administration SetZyno Medical, LLC · 2012
  3. Descendant · 2 generations on · 5 of its ownK151151 U & U Intravascular Administration SetU&U Medical Technology Co, Ltd. · 2015
  4. Descendant · 2 generations on · 1 of its ownK232316 DEKA Infusion System, DEKA Administration SetDeka Research and Development · 2024
  5. Descendant · 3 generations on · 1 of its ownK230343 ProSeal™ Closed System Administration SetEpic Medical Pte., Ltd. · 2023
  6. Descendant · 3 generations on · 1 of its ownK173361 IV Administration SetB.Braun Medical, Inc. · 2018

Showing 5 of 13 descendants. See all descendants

Descendants cleared per year

2012: 12014: 22015: 12016: 12018: 12020: 12022: 12023: 12024: 22025: 12026: 1
2012high 2 (2014) · low 0 (2013)2026

Class I recalls in this family

Most influential descendants

Showing 5 of 13 · See all
  • K120685Zyno Medical Administration SetZyno Medical, LLC · 2012 · cites it directly12descendants
  • K151151U & U Intravascular Administration SetU&U Medical Technology Co, Ltd. · 2015 · 2 generations on5descendants
  • K232316DEKA Infusion System, DEKA Administration SetDeka Research and Development · 2024 · 2 generations on1descendant
  • K230343ProSeal™ Closed System Administration SetEpic Medical Pte., Ltd. · 2023 · 3 generations on1descendant
  • K173361IV Administration SetB.Braun Medical, Inc. · 2018 · 3 generations on1descendant
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K060352Health Line International Corporations,S IV Administrative SetsHealth Line International Corporation2006—
+1K120685Zyno Medical Administration SetZyno Medical, LLC2012—
+2K151151U & U Intravascular Administration SetU&U Medical Technology Co, Ltd.2015—
+2K232316DEKA Infusion System, DEKA Administration SetDeka Research and Development2024—
+3K230343ProSeal™ Closed System Administration SetEpic Medical Pte., Ltd.2023—
+3K173361IV Administration SetB.Braun Medical, Inc.2018—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201210
201421
201510
201611
201810
202010
202210
202310
202420
202510
202610
FIG. 1 — Lineage of K060352, 2006–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

2 devices in this family have a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary; numbers the summary cites that cannot be its predicate are marked – and kept off the family tree.

TypeNumberDeviceApplicantDecidedRecalls
Kept off the family treeK0925126Baxter
Number could not be read
Kept off the family treeK089098Baxter
Not matched in our reading of the summary (scans can blur digits), so it is kept off the family tree

What descends from it? (13)

See all 13

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K120685Zyno Medical Administration SetZyno Medical, LLC201212

Has anything in its family been recalled? (2 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K153193Halo II Ambulatory Infusion System (also with trade names Nimbus II Ambulatory Infusion System, EVAA…Zyno Medical, LLC · 2016 · 2 generations on · ◆ in the 2016 descendants bar of FIG. 13 Class I recalls
  • K140783Halo Ambulatory Infusion SystemZyno Medical, LLC · 2014 · 2 generations on · ◆ in the 2014 descendants bar of FIG. 12 Class I recalls

What does this lineage say?

  • Of its descendants, K120685 (Zyno Medical, LLC, 2012) has gone furthest, with 12 descendants of its own.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The indicated use of health Line International Corporation's IV Administration Sets and Extensions Sets is for administration of fluids from a container to the patents vascular system.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K060352: Health Line International Corporations,S IV Administrative Sets.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K060352

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026